The latest strategy to stretch the supply of the world’s only monkeypox vaccine, Bavarian Nordic’s Jynneos, is frustrating local health officials tasked with distributing the doses, Politico reported Aug. 24.
Vitalant’s blood supply has dropped by nearly 50 percent since early summer, the supplier said Aug. 22, urging people to donate ahead of Labor Day weekend.
An additional 1.8 million doses of the Jynneos monkeypox vaccine will be available for health departments to order starting Aug. 22, according to White House officials.
As monkeypox vaccine supply wanes, members of Congress from New York called on the Biden Administration Aug. 16 to invoke the Defense Protection Act, which they say would ramp up domestic production.
The world’s only pharmaceutical company with an approved monkeypox vaccine said it can’t match the current demand and may move to outsourcing production, Bloomberg reported Aug. 17.